Impact of reporting gram stain results from blood culture bottles on the selection of antimicrobial agents

American Journal of Clinical Pathology

Volumn 132, Issue 1, 2009, Pages 18-25

  Uehara, Yuki ^a,b   Yagoshi, Michiko ^c   Tanimichi, Yumiko ^c   Yamada, Hiroko ^c   Shimoguchi, Kazuo ^c   Yamamoto, Sachiyo ^c   Yanai, Mitsuru ^a   Kumasaka, Kazunari ^a,c  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c NIHON UNIVERSITY   (Japan)

Author keywords

Antimicrobials; Blood culture; Empiric therapy; Gram stain

Indexed keywords

AMIKACIN; ANTIINFECTIVE AGENT; CEFMETAZOLE; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; CLINDAMYCIN PHOSPHATE; GENTAMICIN; HABEKACIN; MEROPENEM; PANIPENEM PLUS BETAMIPRON; PENICILLIN G; SULTAMICILLIN; TOBRAMYCIN; VANCOMYCIN;

ACINETOBACTER; ACINETOBACTER INFECTION; ADOLESCENT; ADULT; AGED; ARTICLE; BACTEREMIA; BLOOD CULTURE; CHILD; CLOSTRIDIUM INFECTION; CONTROLLED STUDY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ENTEROBACTERIACEAE INFECTION; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE COCCI; GRAM STAINING; HUMAN; INFANT; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; PRESCHOOL CHILD; PRIORITY JOURNAL; PSEUDOMONAS; PSEUDOMONAS INFECTION; SCHOOL CHILD; STAPHYLOCOCCUS; STAPHYLOCOCCUS INFECTION; TREATMENT OUTCOME; YEAST;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL INFECTIONS; BACTERIOLOGICAL TECHNIQUES; BLOOD; CHILD; CHILD, PRESCHOOL; FEMALE; GENTIAN VIOLET; HUMANS; INFANT; INFANT, NEWBORN; JAPAN; MALE; MEDICAL RECORDS; MIDDLE AGED; PHENAZINES; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; STAINING AND LABELING; SURVIVAL RATE; YOUNG ADULT;

EID: 67650447411     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/AJCP0H2DAMBXZUSS     Document Type: Article

References (22)

1. Weinstein MP, Towns ML, Quartey SM, et al. The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clin Infect Dis. 1997;24:584-602.
2. Leibovici L, Konisberger H, Pitlik SD, et al. Bacteremia and fungemia of unknown origin in adults. Clin Infect Dis. 1992;14:436-439.
3. Bates DW, Pruess KE, Lee TH. How bad are bacteremia and sepsis? outcomes in a cohort with suspected bacteremia. Arch Intern Med. 1995;155:593-598.
4. Elhanan G, Sarhat M, Raz R. Empiric antibiotic treatment and the misuse of culture results and antibiotic sensitivities in patients with community-acquired bacteremia due to urinary tract infection. J Infect. 1997;35:283-288.
5. Ispahani P, Pearson NJ, Greenwood D. An analysis of community and hospital-acquired bacteremia in a large teaching hospital in the United Kingdom. Q J Med. 1987;63:427-440.
6. Leibovici L, Drucker M, Konigsberger H, et al. Septic shock in bacteremic patients: risk factors, features and prognosis. Scand J Infect Dis. 1997;29:71-75.
7. Leibovici L, Samra Z, Konigsberger H, et al. Long-term survival following bacteremia or fungemia. JAMA. 1995;274:807-812.
8. Setia U, Gross PA. Bacteremia in a communityhospital: spectrum and mortality. Arch Intern Med. 1977;137:1648-1701.
9. Bouchud PY, Bonten M, Marchetti O, et al. Antimicrobial therapy for patients with severe sepsis and septic shock: an evidence-based review. Crit Care Med. 2004;32(11 suppl):S495-S512.
10. Baron EJ, Weinstein MP, Dunne WM, et al. Incubation and examination of blood cultures. In: Baron EJ, ed. Cumitech 1C: Blood Cultures IV. Washington, DC: ASM Press; 2005:13-17.
11. Hautala T, Syrjälä H, Lehtinen V, et al. Blood culture Gram stain and clinical categorization based empirical antimicrobial therapy of bloodstream infection. Int J Antimicrob Agents. 2005;25:329-333.
12. Bouza E, Sousa D, Munoz P, et al. Bloodstream infections: a trial of the impact of different methods of reporting positive blood culture results. Clin Infect Dis. 2004;39:1161-1169.
13. Cunney RJ, McNamara EB, Alansari N, et al. The impact of blood culture reporting and clinical liaison on the empiric treatment of bacteremia. J Clin Pathol. 1997;50:1010-1012.
14. Munson EL, Diekema DJ, Beekman SE, et al. Detection and treatment of bloodstream infection: laboratory reporting and antimicrobial management. J Clin Microbiol. 2003;41:495-497.
15. Saito T, Aoki Y, Mori Y, et al. Blood culture examinations at a community hospital without a microbiology laboratory: using an automated blood culture system and performing a Gram stain on positive culture bottles in the institution. J Infect Chemother. 2004;10:239-241.
16. York MK. Gram stain. In: Isenberg HD, ed. Clinical Microbiology Procedures Handbook [with 2007 updates]. 2nd ed. Vol 1. Washington, DC: ASM Press; 2004:3.2.1.1-3.2.1.18.
17. Vidal F, Mensa J, Almela M, et al. Epidemiology and outcome of Pseudomonas aeruginosa bacteremia, with special emphasis on the influence of antibiotic treatment. Arch Intern Med. 1996;156:2121-2126.
18. Gudlaugsson O, Gillespie S, Lee K, et al. Attribute mortality of nosocomial candidemia, revisited. Clin Infect Dis. 2003;37:1172-1177.
19. Schreckenberger PC, Daneshvar MI, Robbin S, et al. Acinetobacter, Achromobacter, Chryseobacterium, Moraxella, and other nonfermentative gram-negative rods. In: Murray PR, Baron EJ, Pfaller MA, et al, eds. Manual of Clinical Microbiology. 8th ed. Washington, DC: ASM Press; 2004:749-751.
20. Land KH, Tillan M. Errors in interpretation of Gramstains from positive blood cultures. Am J Clin Pathol. 2006;126:686-690.
21. Sogaard M, Norgaard M, Schonheyder H. First notification of positive blood cultures and the high accuracy of the Gram stain report. J Clin Microbiol. 2007;45:1113-1117.
22. Beekmann SE, Diekema DJ, Chapin KC, et al. Effects of rapid detection of bloodstream infections on length of hospitalization and hospital charges. J Clin Microbiol. 2003;41:3119-3125.